These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12029630)

  • 1. The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis.
    Wong F; Liu P; Blendis L
    Hepatology; 2002 Jun; 35(6):1449-58. PubMed ID: 12029630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.
    Therapondos G; Hol L; Benjaminov F; Wong F
    Hepatology; 2006 Sep; 44(3):640-9. PubMed ID: 16941706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
    Wong F; Logan A; Blendis L
    Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of a dynamic aldosterone-independent distal tubular control of renal sodium excretion in compensated liver cirrhosis.
    Sansoè G; Silvano S; Rosina F; Smedile A; Rizzetto M
    J Intern Med; 2005 Apr; 257(4):358-66. PubMed ID: 15788006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
    Sellars L; Shore AC; Mott V; Wilkinson R
    Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis.
    Girgrah N; Liu P; Collier J; Blendis L; Wong F
    Gut; 2000 Jan; 46(1):114-20. PubMed ID: 10601066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of posture on central blood volume in patients with preascitic cirrhosis on a sodium-restricted diet.
    Wong F; Liu P; Allidina Y; Blendis L
    Hepatology; 1996 May; 23(5):1141-7. PubMed ID: 8621146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of canrenone in patients with preascitic cirrhosis.
    La Villa G; Barletta G; Romanelli RG; Laffi G; Del Bene R; Vizzutti F; Pantaleo P; Mazzocchi V; Gentilini P
    Hepatology; 2002 Jun; 35(6):1441-8. PubMed ID: 12029629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium homeostasis with chronic sodium loading in preascitic cirrhosis.
    Wong F; Liu P; Blendis L
    Gut; 2001 Dec; 49(6):847-51. PubMed ID: 11709521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis.
    Wong F; Liu P; Lilly L; Bomzon A; Blendis L
    Clin Sci (Lond); 1999 Sep; 97(3):259-67. PubMed ID: 10464050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal tubular events following passage from the supine to the standing position in patients with compensated liver cirrhosis: loss of tubuloglomerular feedback.
    Sansoè G; Biava AM; Silvano S; Ferrari A; Rosina F; Smedile A; Touscoz A; Bonardi L; Rizzetto M
    Gut; 2002 Nov; 51(5):736-41. PubMed ID: 12377816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal hemodynamics and the renin-angiotensin system in cirrhosis.
    Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J
    Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
    Tesar V; Spicák J; Horký K; Zabka J; Widimský J; Jedlicka J; Marecek Z
    Cas Lek Cesk; 1994 Feb; 133(4):111-5. PubMed ID: 8137382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis.
    Sansoè G; Ferrari A; Castellana CN; Bonardi L; Villa E; Manenti F
    Clin Sci (Lond); 2002 Jan; 102(1):91-8. PubMed ID: 11749665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal sodium retention during upright posture in preascitic cirrhosis.
    Bernardi M; Di Marco C; Trevisani F; Fornalè L; Andreone P; Cursaro C; Baraldini M; Ligabue A; Tamè MR; Gasbarrini G
    Gastroenterology; 1993 Jul; 105(1):188-93. PubMed ID: 8514034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan may modulate erythropoietin production.
    Donnelly SM; Miller JA
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):255-60. PubMed ID: 11881132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin-angiotensin-aldosterone system in human hepatic cirrhosis.
    Bernardi M; Gasbarrini G
    Isr J Med Sci; 1986 Feb; 22(2):70-7. PubMed ID: 3512474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
    Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M
    Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.